Ganirelix Subcutaneous and Moxetumomab Pasudotox-tdfk
Determining the interaction of Ganirelix Subcutaneous and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ganirelix
Brand name: Antagon, Ganirelix Acetate
Synonyms: Ganirelix
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ganirelix Subcutaneous-Moxetumomab pasudotox-tdfk Intravenous
- Ganirelix Subcutaneous-Moxifloxacin
- Ganirelix Subcutaneous-Moxifloxacin (Systemic)
- Ganirelix Subcutaneous-Moxifloxacin Hydrochloride
- Ganirelix Subcutaneous-Moxifloxacin Injection
- Ganirelix Subcutaneous-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Ganite
- Moxetumomab Pasudotox-tdfk-Gantrisin
- Moxetumomab Pasudotox-tdfk-Gantrisin Pediatric
- Moxetumomab Pasudotox-tdfk-Garamycin
- Moxetumomab Pasudotox-tdfk-Garamycin Injection
- Moxetumomab Pasudotox-tdfk-Garamycin Topical